MoneyWorks4Me

The revenue zoomed 8.32% to Rs. 14941.40 millions for the quarter ended September 2023 as compared to Rs. 13793.30 millions during the corresponding quarter last year.Net profit stood at Rs. 3129.40  millions  compared to Rs. 2655.20 millions in the corresponding previous quarter,high by 17.86%.Operating Profit saw a handsome growth to 4363.90 millions from 3768.30 millions in the quarter ended September 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 14941.40 13793.30 8.32 29731.40 26834.50 10.80 53487.30 49133.20 8.86
Other Income 555.10 336.80 64.82 1115.10 602.90 84.96 1541.50 831.60 85.37
PBIDT 4363.90 3768.30 15.81 8473.90 6735.90 25.80 13597.80 11649.30 16.73
Interest 31.30 39.70 -21.16 64.70 81.90 -21.00 159.90 191.00 -16.28
PBDT 4332.60 3728.60 16.20 8409.20 6654.00 26.38 13437.90 11458.30 17.28
Depreciation 178.40 174.70 2.12 350.10 348.20 0.55 699.70 661.00 5.85
PBT 4154.20 3553.90 16.89 8059.10 6305.80 27.80 12738.20 10797.30 17.98
TAX 1024.80 898.70 14.03 2027.30 1594.20 27.17 3244.10 2810.30 15.44
Deferred Tax -18.00 -18.30 -1.64 -35.60 -30.50 16.72 -11.90 -1.30 815.38
PAT 3129.40 2655.20 17.86 6031.80 4711.60 28.02 9494.10 7987.00 18.87
Equity 212.50 212.50 0.00 212.50 212.50 0.00 212.50 212.50 0.00
PBIDTM(%) 29.21 27.32 6.91 28.50 25.10 13.54 25.42 23.71 7.22
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..